It is associated with connective tissue disorders (such as scleroderma), myositis-specific autoantibodies (i.e., anti-SRP and anti-HMGCR), malignancy, viral infections (HIV or hepatitis C), or immune checkpoint inhibitors. Here, HMGCR is linked to myositis disease.